ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $65,097,000 | +177.1% | 1,405,081 | +45.8% | 0.19% | +177.6% |
| Q1 2019 | $23,489,000 | +11644.5% | 963,427 | +6778.7% | 0.07% | +6600.0% |
| Q4 2018 | $200,000 | -8.3% | 14,006 | -2.2% | 0.00% | 0.0% |
| Q3 2018 | $218,000 | -40.1% | 14,326 | -33.9% | 0.00% | 0.0% |
| Q2 2018 | $364,000 | +2.8% | 21,673 | -0.1% | 0.00% | 0.0% |
| Q1 2018 | $354,000 | +785.0% | 21,692 | +92.1% | 0.00% | – |
| Q2 2016 | $40,000 | +21.2% | 11,290 | 0.0% | 0.00% | – |
| Q1 2016 | $33,000 | -31.2% | 11,290 | 0.0% | 0.00% | – |
| Q4 2015 | $48,000 | -11.1% | 11,290 | -4.6% | 0.00% | – |
| Q3 2015 | $54,000 | -38.6% | 11,840 | 0.0% | 0.00% | – |
| Q1 2015 | $88,000 | – | 11,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |